...
首页> 外文期刊>Journal of orthopaedic science : >Use of glycyrrhizin in prevention of tissue damage caused by ischemia-reperfusion in rabbit hind limbs.
【24h】

Use of glycyrrhizin in prevention of tissue damage caused by ischemia-reperfusion in rabbit hind limbs.

机译:甘草甜素在预防兔后肢缺血再灌注引起的组织损伤中的用途。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Glycyrrhizin, an agent that can bind to selectins and inhibit their ability to bind neutrophils, was found to be effective in preventing tissue edema caused by ischemia-reperfusion in a rabbit model. METHODS: Complete ischemia was produced by applying a tight Esmarch tourniquet to the hind limbs of 24 Japanese white rabbits. Immediately before and 1 h after release of the tourniquet, 12 animals were given glycyrrhizin intravenously; 12 controls received saline. RESULTS: The mean relative increase in the circumference of the shins before and after ischemia-reperfusion with or without glycyrrhizin treatment was 4.6% +/- 2.4% and 9.6% +/- 4.2%, respectively, indicating that tissue edema caused by the ischemia-reperfusion was significantly attenuated by glycyrrhizin. Histological studies of cross sections of the anterior tibial muscle 24 h after reperfusion showed a significant reduction in the incidence of necrotic muscle fibers in the glycyrrhizin-treated animals compared with the controls that did not receive glycyrrhizin. The mRNA levels of P- and E-selectin 24 h after reperfusion were significantly higher in the ischemic anterior tibial muscle than in the nonischemic normal muscle. After 24 h of reperfusion, the mean activity of myeloperoxidase, a neutrophil-specific enzyme, in the anterior tibial muscles of the group given glycyrrhizin (0.0022 +/- 0.0013 absorbance units) was lower than that of the untreated group (0.027 +/- 0.026 absorbance units). CONCLUSIONS: These data suggest that glycyrrhizin treatment is effective in suppressing the acute inflammatory reaction or edema following ischemia-reperfusion and might be potentially useful in clinical practice for preventing ischemia-reperfusion injuries to the extremities.
机译:背景:甘草甜素是一种可与选择素结合并抑制其与中性粒细胞结合能力的药物,已被发现可有效预防兔模型缺血再灌注引起的组织水肿。方法:通过对24只日本白兔的后肢施加紧紧的Esmarch止血带产生完全缺血。在释放止血带之前和之后1小时,立即给12只动物静脉注射甘草甜素。 12名对照接受了盐水。结果:在有或没有甘草甜素治疗的缺血再灌注前后,胫骨的周长平均相对增加分别为4.6%+/- 2.4%和9.6%+/- 4.2%,表明由缺血引起的组织水肿甘草酸显着减弱了再灌注。再灌注后24 h,胫骨前肌横截面的组织学研究表明,与未接受甘草甜素的对照组相比,经甘草甜素处理的动物中坏死肌纤维的发生率显着降低。缺血性胫前肌中再灌注后24 h P-和E-选择素的mRNA水平显着高于非缺血性正常肌。再灌注24小时后,给予甘草甜素的组的胫骨前肌肉中的髓过氧化物酶(一种中性粒细胞特异性酶)的平均活性(0.0022 +/- 0.0013吸光度单位)低于未治疗组(0.027 +/-)。 0.026吸光度单位)。结论:这些数据表明,甘草甜素治疗可有效抑制缺血再灌注后的急性炎症反应或水肿,并且可能在预防四肢缺血再灌注损伤的临床实践中可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号